Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fountain Asset is a Canadian publicly traded merchant bank and investment company that provides debt and equity financing solutions, asset-based lending, mergers and acquisitions advisory, operational support, and go-public transaction services to small and mid-sized companies in North America. The company operates across multiple sectors, including manufacturing, retail, financial services, technology, cannabis, biotechnology, oil and gas, mining, and cryptocurrency, but it is not itself a life sciences or biopharmaceutical operating company. Fountain describes its business as opportunistic investing and capital structuring rather than therapeutic product development. For a biotech analyst, the key point is that Fountain may finance or advise healthcare and biotechnology companies, but it does not appear to have a proprietary drug pipeline, therapeutic platform, or clinical-stage programs of its own.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fountain Asset.